These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34955835)

  • 1. Case Report: Monitoring Vancomycin Concentrations and Pharmacokinetic Parameters in Continuous Veno-Venous Hemofiltration Patients to Guide Individualized Dosage Regimens: A Case Analysis.
    Chen J; Huang X; Lin Z; Li C; Ding H; Du J; Li L
    Front Pharmacol; 2021; 12():763575. PubMed ID: 34955835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Individualized vancomycin dosing for a patient diagnosed as severe acute pancreatitis with concurrent extracorporeal membrane oxygenation and continuous veno-venous hemofiltration therapy: a case report].
    He N; Yan YY; Ying YQ; Yi M; Yao GQ; Ge QG; Zhai SD
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 50(5):915-920. PubMed ID: 30337758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of vancomycin exposure target and individualized dosing recommendations for critically ill patients undergoing continuous renal replacement therapy.
    Wang C; Chen J; Yang B; Li S; Zhang Y; Chen L; Wang T; Dong Y
    Pharmacotherapy; 2023 Mar; 43(3):180-188. PubMed ID: 36714991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin pharmacokinetics during high-volume continuous venovenous hemofiltration in critically ill septic patients.
    Petejova N; Martinek A; Zahalkova J; Duricova J; Brozmannova H; Urbanek K; Grundmann M; Plasek J; Kacirova I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):65-72. PubMed ID: 23132513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous infusion versus intermittent infusion of vancomycin in critically ill patients undergoing continuous venovenous hemofiltration: a prospective interventional study.
    Xu J; Duan L; Li J; Chen F; Xu X; Lu J; Zhuang Z; Cao Y; Yuan Y; Liu X; Sun J; Zhou Q; Shi L; Tang L
    BMC Infect Dis; 2022 Aug; 22(1):667. PubMed ID: 35918657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose Optimization of Vancomycin for Critically Ill Patients Undergoing CVVH: A Prospective Population PK/PD Analysis.
    Wang C; Zhang C; Li X; Zhao S; He N; Zhai S; Ge Q
    Antibiotics (Basel); 2021 Nov; 10(11):. PubMed ID: 34827330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of vancomycin in continuous veno-venous hemofiltration].
    Gu Q; Zhu ZH; Ge M; Ge WH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Feb; 15(2):114-6. PubMed ID: 12857476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing Antimicrobial Dosing for Critically Ill Patients with MRSA Infections: A New Paradigm for Improving Efficacy during Continuous Renal Replacement Therapy.
    Chen J; Li S; Wang Q; Wang C; Qiu Y; Yang L; Han R; Du Q; Chen L; Dong Y; Wang T
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of levofloxacin in critically ill patients with renal failure: influence of continuous veno-venous hemofiltration.
    Bellmann R; Egger P; Gritsch W; Bellmann-Weiler R; Joannidis M; Dunzendorfer S; Wiedermann CJ
    Int J Clin Pharmacol Ther; 2002 Apr; 40(4):142-9. PubMed ID: 11996208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of continuous renal replacement therapy on linezolid pharmacokinetic/pharmacodynamics: a systematic review.
    Villa G; Di Maggio P; De Gaudio AR; Novelli A; Antoniotti R; Fiaccadori E; Adembri C
    Crit Care; 2016 Nov; 20(1):374. PubMed ID: 27863531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.
    Joy MS; Matzke GR; Frye RF; Palevsky PM
    Am J Kidney Dis; 1998 Jun; 31(6):1019-27. PubMed ID: 9631848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of different doses in continuous veno-venous hemofiltration on plasma lactate in critically ill patients.
    Liu Y; Ouyang B; Chen J; Chen M; Ma J; Wu J; Huang S; Li L; Liu Z; Guan X
    Chin Med J (Engl); 2014; 127(10):1827-32. PubMed ID: 24824239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin therapy in critically ill patients on continuous renal replacement therapy; are we doing enough?
    Omrani AS; Mously A; Cabaluna MP; Kawas J; Albarrak MM; Alfahad WA
    Saudi Pharm J; 2015 Jul; 23(3):327-9. PubMed ID: 26106281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of continuous venovenous hemofiltration on vancomycin trough concentrations in critically ill children.
    Peng L; Gao Y; Zhang G; Tian X; Xu H; Yu Q; Cheng J; Li Y; Li Q; Chen Y; Zhao W; Luo Z
    Ann Transl Med; 2021 Feb; 9(3):224. PubMed ID: 33708851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Extracorporeal Membrane Oxygenation on the New Vancomycin Dosing Regimen in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration.
    Yang CJ; Wu CW; Wu CC
    Ther Drug Monit; 2018 Jun; 40(3):310-314. PubMed ID: 29746432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.
    Pea F; Viale P; Pavan F; Furlanut M
    Clin Pharmacokinet; 2007; 46(12):997-1038. PubMed ID: 18027987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics and individualized dosing of vancomycin for critically ill patients receiving continuous renal replacement therapy: the role of residual diuresis.
    Yu Z; Liu J; Yu H; Zhou L; Zhu J; Liang G; Yang Y; Zheng Y; Han Y; Xu J; Han G; Yu L; Zhao Y
    Front Pharmacol; 2023; 14():1298397. PubMed ID: 38223197
    [No Abstract]   [Full Text] [Related]  

  • 18. Levetiracetam Pharmacokinetics in a Patient with Intracranial Hemorrhage Undergoing Continuous Veno-Venous Hemofiltration.
    Van Matre ET; Mueller SW; Fish DN; MacLaren R; Cava LF; Neumann RT; Kiser TH
    Am J Case Rep; 2017 Apr; 18():458-462. PubMed ID: 28446744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin and tobramycin clearance in an infant during continuous hemofiltration.
    Armstrong DK; Hidalgo HA; Eldadah M
    Ann Pharmacother; 1993 Feb; 27(2):224-7. PubMed ID: 8439703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole.
    Muhl E; Martens T; Iven H; Rob P; Bruch HP
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):671-8. PubMed ID: 11214774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.